Divalproex Sodium NDC 55111-534

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-534Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0534Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-534-01	55111053401	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-534-01)Marketed from Aug 11, 2013
55111-534-05	55111053405	500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-534-05)Marketed from Aug 11, 2013
55111-534-30	55111053430	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-534-30)Marketed from Aug 11, 2013
55111-534-60	55111053460	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-534-60)Marketed from Aug 11, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Divalproex Sodium
Generic name (nonproprietary): divalproex sodium
Active ingredients: Divalproex sodium — 500 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Dr. Reddy's Laboratories Ltd
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090070
Marketing start: Aug 11, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 55111-534_65caa41f-3e0b-c418-b098-f4d0d8d9f31dSPL ID 65caa41f-3e0b-c418-b098-f4d0d8d9f31dSPL set ID fa823ee0-0c69-6b85-da1e-9bb2e2150ea5RxCUI 1099569UNII 644VL95AO6UPC 0355111534013
Pharmacologic class: Anti-epileptic Agent; Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111053401 followed by a unit qualifier and the quantity

Package 55111-0534-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 7, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Divalproex sodium extended-release tablet is indicated for: Acute treatment of manic or mixed episodes associated with bipolar disorder, with or without psychotic features (1.1) Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures (1.2) Prophylaxis of migraine headaches (1.3) 1.1 Mania Divalproex sodium extended-release tablet is a valproate and is indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, with or without psychotic features. A manic episode is a distinct period of abnormally and persistently elevated, …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090070

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090070
Product	Strength	Form · route	Labeler	Product NDC
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-4100